Loomio

Proposal on Non Patentable Medicine for Online PPI GA 29th March

AR Andrew Reitemeyer Public Seen by 209

Proposal from PPDE
The proposal was not translated well so please see the Pirate Times article for an explanation

http://piratetimes.net/lost-in-translation-an-interview-with-gregory-engels/

Official motion: http://wiki.pp-international.net/Online_GA_2015/Motions#MO-1_Access_to_medicine

AR

Poll Created Mon 23 Mar 2015 10:20PM

Should we support PPDE Proposal on Non Patentable Medicine? Closed Thu 26 Mar 2015 7:04AM

Results

Results Option % of points Voters
Agree 75.0% 3 DU BV HM
Abstain 25.0% 1 AR
Disagree 0.0% 0  
Block 0.0% 0  
Undecided 0% 16 DS AJ TF KT TJ DP CM BK M RU PA AB DU RF CW MD

4 of 20 people have participated (20%)

AR

Andrew Reitemeyer
Abstain
Wed 25 Mar 2015 2:35AM

I am not happy with PPI taking stands on policy even if we agree.

DS

Danyl Strype Thu 14 May 2015 3:20AM

Excuse we while I catch up ;) @andrewreitemeyer your objection here seems to feed into the discussion on our membership of PPI. Am I correct in thinking that you believe an international Pirates network should focus on stewarship of shared services, and facilitating cooperation between parties, and not be doing policy work?

AR

Andrew Reitemeyer Fri 15 May 2015 6:54AM

Yes also these policies originate from a fraction the board itself and not the general assembly. PPI looks to be functioning like a politburo where the policy decisions are made by the board and rubber stamped by the GA. Far removed from the grass roots basis of the movement.

DS

Danyl Strype Tue 19 May 2015 8:36PM

The process you describe does seem less democratic than ours. That said, I have no objection to importing good policies from other parties, Pirate or otherwise.

Policy-wise I would actually go much further than PPDE. I don't think it's ok to patent chemistry (as drug patents do), any more than it's ok to patent mathematics (as software patents do). Patents should only cover new methods for making a drug, not grant a monopoly on the molecular structure of the active ingredients.

BTW This seems to be a policy discussion, so I'm moving it to the Policy Group.